Related Experiment Video
Updated: May 2, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Regulation of p53 level by UBE4B in breast cancer
Ying Zhang1, Yanrong Lv1, Yongyang Zhang2
1Department of Breast Surgery, QiLu Hospital, Jinan, China.
Abstract:
p53 is possibly the most important mammalian tumor suppressor and it is mutated or lost in more than half of all human cancers. The stability of p53 is primarily determined by the RING domain E3 ubiquitin ligase Hdm2, which targets p53 for proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation. UBE4B has been shown to physically interact with p53 and Hdm2 and to negatively regulate p53 stability and function. However, no one has determined whether UBE4B promotes p53 degradation in breast cancer. In this study, UBE4B promoted the degradation and ubiquitination of p53 to inhibit the apoptosis of cancer cells and promote tumorigenesis. Our results indicate that UBE4B regulates p53 in breast cancer and could be a viable target for developing new therapeutic strategies for breast cancer treatment.
Insights
UBE4B promotes the degradation of the tumor suppressor p53 in breast cancer cells. This mechanism inhibits cancer cell apoptosis and promotes tumor growth, suggesting UBE4B as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- p53 is a critical tumor suppressor frequently lost or mutated in human cancers.
- Hdm2, an E3 ubiquitin ligase, regulates p53 stability and function.
- UBE4B interacts with p53 and Hdm2, suggesting a role in p53 regulation.
Purpose of the Study:
- To investigate the role of UBE4B in regulating p53 stability and function specifically within breast cancer.
- To determine if UBE4B promotes p53 degradation in the context of breast cancer.
Main Methods:
- Co-immunoprecipitation assays to confirm protein interactions.
- Western blotting to assess protein levels and ubiquitination.
- Cell viability and apoptosis assays to evaluate functional consequences.
Main Results:
- UBE4B was found to promote the degradation and ubiquitination of p53 in breast cancer cells.
- UBE4B activity led to the inhibition of cancer cell apoptosis.
- Increased UBE4B expression correlated with enhanced tumorigenesis.
Conclusions:
- UBE4B plays a significant role in regulating p53 stability and function in breast cancer.
- UBE4B promotes breast cancer progression by inhibiting p53-mediated apoptosis.
- UBE4B represents a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Negative Regulator Molecules
Regulation of the Unfolded Protein Response
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

